A stereoselective synthesis of (R)-(-)-rolipram from L-glutamic acid by Díaz Martínez, Adolfo et al.
May 1997 SYNTHESIS 559
A Stereoselective Synthesis of (R)-( - )-Rolipram from L-Glutamic Acid . ~O-OE-;'~..,(,
'//:;) -1Adolfo Diaz, Jorge G. Siro, José L. García-Navío, Juan 1. Vaquero, Julio Alvarez-Builla* (g B/Bl/OTE ~\
Departamento de Química Orgánica, Universidad de Alcalá, E-28871 Alcalá de Henares, Madrid, Spain """1< C4 ~
Fax + 34(1)8854686; Internet: jalvarez@quimor.alcala.es '?~3~'
Received 20 September 1996; revised 13 November 1996
The key step for the planned synthesis should be the
stereoselective introduction of the aryl moiety. The elec-
tron-withdrawing Boc group, attached to the amide
In the present communication we describe a Michael-type
approach using a modified pyroglutamic derivative as
the templa te to induce the stereoselectivity. The use of
natural ct-amino acids as starting materials for the syn-
thesis of enantiomerically pure compounds has gained
interest in recent times since the single chiral center pro-
vides a useful building block.7 L-Glutamic acid, the least
expensive of all amino acids, is, due to its versatility and
availability, one of the most used in synthesis. A simple
retrosynthetic analysis (Scheme 2) led us to consider a
modified pyroglutamatic acid derivative 28 as a useful
starting material for an asymmetric synthesis of (R)-( - )-
rolipram (1).
A stereoselective synthesis of (R)-( - )-rolipram from L-glutamic
acid is described. The key step is a stereoselective Michael addition
of an arylcuprate to a modified pyroglutamic derivative which acts
as the template to induce the stereoselectivity. Facile manipulation
ofthe enantiomerically pure Michael product afforded the expected
therapeutic agent.
(R)-( - )-Rolipram (1), a potent inhibitor of the cardiac
cyclic AMP phosphodiesterase (cAMP PDE) enzyme
found in brain tissue, is of great interest as a therapeutic
agent for the treatment of central nervous system disor-
ders.1 In a recent paper2 some of the enantioselective
syntheses of this compound have been reviewed. In
Scheme 1, four retrosynthetic disconnections are shown
for (R)-( - )-rolipram (1). Disconnections a and b are
based on the same concept, where a conjugated Michael
addition is employed as the key step. Whereas in route
a, the stereochemistry of the final product is controlled
by the stereoselective conjugate addition of RCuCNLi
to a chiral ct,{J-unsaturated bicyclic lactam,3 the diaste-
reoselectivity in route b is controlled by the chirality of
the enolate of a N-acetyloxazolidone, which behaves as
the nucleophile in the reaction with a suitable nitrosty-
rene.4 In route e, two synthetic approaches developed by
Mulzer et al., 5 using a suprafacial Claisen rearrangement
are summarized. Finally, route d shows the most recent
approach which involves an enantioselective deprotona-
tion of a cyclobutanone derivative using (S,S')-ct,ct' -di-




























nitrogen, activates the tX,f3-unsaturatedsystem toward the
conjugate" addition of organocuprates and a bulky
protected alcohol 2 (R=CH20SiPh2Bu-t) provides the
steric hindrance necessary to control the stereoselectivity
in the conjugate addition of the aryl cuprate 3.
The preparation of the chiral doubly protected tX,f3-un-
saturated y-Iactam 2 from L-glutamic acid is well docu-
mented in the literature.8 The required bromoarene 43
was obtained in a 4 step synthesis from 2-methoxyphenol
via: a) O-benzoylation, b) regioselective electrophylic
bromination of the O-protected 2-methoxyphenol, c) de-
protection of the benzoyl moiety and finally, d) O-alky-
lation with cyclopentyl bromide.
The reaction of the aryl cuprate 3, produced in situ from
aryl bromide 4, BuLi and a suspension of CuBr·SMe2,
with the unsaturated lactam 2 in the presence of trimeth-
ylsilyl chloride9 took place in good yield to produce the
expected isomer 5 (Scheme 3) where the bulkyl protected
silyloxy group induces the newly formed stereocenter,
which could be confirmed by 1H NMR spectroscopy
(analysis of the crude reaction mixture showed the
presence of a single product, de >95%). Standard
deprotection of O-Si bond in 5 failed with tetrabutyl-
ammonium fluoride/o but triethylammonium fluoridell
worked quite well, although a long reaction time was
required. The oxidation of the primary alcohol 6 using
Jones reagent produced the pyroglutamic acid derivative
7. Decarboxylation12 simultaneously resulted in the de-
protection of the Boc group, affording (R)-rolipram (1).
Although the direction and magnitude of the optical ro-
tation for this compound is identical to previously re-
ported values, we carried out a chiral HPLC analysis13
for this synthetic material and the racemate, indicating
more than 99 % enantiomeric purity. The racemate (± )-1
was simultaneously obtained from achirall-tert-butoxy-
carbonyl-l ,5-dihydro-2H-pyrrol-2-one (8)14 by reaction
with the aryl cuprate 3.
In conclusion, this work represents an enantioselective
synthesis of R-( - )-rolipram using a Michael-type ap-
proach from readily available starting materials. The syn-
thesis of alternatively modified pyroglutamic precursors
are now in progress in order to shorten the process and
results will be reported in due course.
All solvents and reagents were purchased from commercial sources
and used as received unless otherwise indicated. Reactions with
organometallics were run in flame dried glassware under an argon
atmosphere. THF and Et20 were dried over sodium wire and
distilled under argon prior to use. 1H NMR and l3c NMR data
were recorded on a Varia n Unity (300 MHz) using CDCl3 as solvento
Melting points were determined on a Büchi apparatus and are not
corrected. Optical rotations were measured with a Perkin-Elmer
241 polarimeter using MeOH as solvento Chromatographic sepa-
rations were performed by using 230-400 mesh silica gel. (5S)-1-
ter t-Butoxycarbony 1-5-( ter t-bu tyldipheny Isiloxy )methyl-1 ,5-dihy-
dro-2H-pyrrol-2-one (2)8 and 1-tert-butoxycarbonyl-1,5-dihydro-
2H-pyrrol-2-one 814 were prepared as described in the literature.
4-Bromo-2-eyclopentyloxyanisole (4):
2-Methoxypheny/ Benzoate: An ice cooled solution of 2-methoxy-
phenol (15 g, 0.12 mol) in H20 (75 mL) was treated with an aqueous
solution of NaOH (75 mL 20%), then benzoyl chloride (16.99 g,







5 R = CH20SiPh2'Bu
(±)-1 R= H












i) n-BuLi 1CuBr.SMe2/THF 1-35·C
ii) Me3SiCI/-78·C
iii) TEAF 1 THF 1 r.t
iv) Jones reagent 1 o ·C
v) N-methylmorpholine 1 isobutyl chloroformate 1
N-hydroxy-2-lhiopyridone 1TEA 1THF 1-15·C Ilighl
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bath for 1 h and then at r.t. for 2 h. The solution was extracted
with CH2Cl2 (2 X 100 mL) and subsequently washed with H20
(2 X 50 mL). The organic layer was dried (MgS04) and on removal
of the solvent 2-methoxyphenyl benzoate was obtained as a solid
(14.14 g, 51 %); mp 58-60°C.
5-Bromo-2-methoxyphenol: A solution of Br 2 (10.03 g, 0.063 mol)
in AcOH (10 mL) was slowly added to a solution of the above
benzoate (13.02 g, 0.057 mol) in AcOH (65 mL). The mixture was
stirred at r.t. for 24 h and then more Br2 (3.22 g, 0.020 mol) in the
same solvent (15 mL) was added, and the mixture stirred for 24 h.
The residue which was obtained by removal of the solvent at r.t.
was dissolved in CH2Cl2 (100 mL) and washed with a satd solution
of KHC03. The organic layer was dried and evaporated in vacuo
to give an oily product which on standing in pentane yielded 5-
bromo-2-methoxyphenol as a solid (10.98 g, 70%); mp 62-64°C
(Lit.3 mp 60-62°C).
4-Bromo-2-cyclopentylox)'Gnisole (4): To a solution of the above
phenol (6.23 g, 0.038 mol) in anhyd DMF (50 mL), were added
successively powered anhyd K2C03 (6.36 g, 0.046 mol) and cyclo-
pentyl bromide (6.63 g, 0.046 mol). The mixture was stirred at 60°C
for 24 h. The solvent was evaporated in vacuo and the residue
triturated with H20 and the inorganic residue removed by filtration.
The solution was extracted with CH2Cl2 (40 mL), dried (MgS04)
and the solvent was removed in vacuo to yield 4 as an oily product
(7.24 g, 87 %), which was used without further purification in the
next step.
IHNMR (CDCI3): b = 7.01-6.97 (m, 2H), 6.72 (d, 1 H,
J = 8.4 Hz), 4.74-4.72 (m, 1 H), 3.73 (s, 3 H), 1.94-1.79 (m, 6 H),
1.64-1.58 (m, 2 H).
(4R,5S)-I-tert-Butoxycarbonyl-5-tert-buty Idiphenylsiloxymethyl-4-
(3-cyclopentylox y-4-methoxy pheny I)pyrrolidine- 2-one (5):
To a cooled (- 35°C) solution of 4 (1.79 g, 6.6 mmol) in anhyd
Et20 was added a 1.6 M solution of BuLi in hexanes (4.13 mL,
6.6 mmol). The precipitate formed was redissolved by the slow ad-
dition of anhyd THF and siphoned to a suspension of CuBr'SMe2
(0.682 g, 3.3 mmol) in anhyd Et20 (20 mL). After 1 h the suspension
was cooled at - 78°C and a solution of 2 (300 mg, 0.66 mmol) and
Me3SiCI (0.17 mL, 1.32 mmol) in anhyd Et20 (10 mL) was added.
The mixture was stirred for 1.5 h at - 78°C, and then quenched
with NH4C1 solution. The organic layer was washed with NH4C1
solution, until the blue color of the water phase disappeared, and
then dried (MgS04). Evaporation ofthe solvent gave an oily residue
which was purified by column chromatography (hexane/EtOAc,
4:1) to furnish 5 (360mg, 84%) as a white solid; mp 46-48°C;
[ajo -19.8 (c = 0.5, MeOH).
IHNMR (CDCI3): b=7.71-7.67 (m, 4H), 7.49-7.40 (m, 6H),
6.82 (d, J = 8.8 Hz, 1H), 6.70-6.68 (m, 2H), 4.75-4.73 (m, 1 H),
4.13-4.10 (m, 1 H), 3.95 (dd, J = 10.5, 4.9 Hz, 1 H), 3.85 (s, 3 H),
3.84 (dd, J = 10.5,2.4 Hz, 1 H), 3.46 (dt, J = 9.3,2.6 Hz, 1 H), 3.18
(dd, J = 17.8, 9.3 Hz, 1 H), 2.57 (dd, J = 17.8, 2.6 Hz, 1 H),
1.94-1.81 (m, 6H), 1.65-1.60 (m, 2H), 1.44 (s, 9H), 1.12 (s, 9H).
13CNMR (CDCl3): b = 174.2, 149.6, 149.1, 148.1, 136.6, 135.6,
133.0,130.0,127.9,118.2,113.0,112.2,83.0,80.4,67.0, 64.2, 56.1,
39.9,38.2,32.8,28.0,26.9,24.1, 19.2.
IR (CHBr 3): v = 1778, 1737, 1710, 1305, 1257, 1143 cm -l.
Anal. calcd for C38H49N06Si: C, 70.88; H, 7.67; N, 2.18. Found:
C, 70.70; H, 7.80; N, 2.08.
(4R ,5S)-I-tert-Butoxycarbonyl-4-(3-cyclopentyloxy-4-methoxy-
phenyl)-5-h ydroxymethy Ipyrro Iidin-2-one (6):
To a solution of 5 (2.72 g, 4.22 mmol) in THF (60 mL), was added
Et3N·HF (2.05 g, 16.90 mmol). The mixture was stirred for 5 d at
r.t. and diluted with EtOAc (120 mL), washed with NH4C1 solution
(3 x 60 mL) and extracted with EtOAc (2 x 60 mL). The combined
organic layers were dried (MgS04) and the solvent evaporated. The
remaining oil was purified by column chromatography (hexane/
EtOAc, 1: 1) to give 1.57 g (92 %) of a colourless oil, which cry-
stallized upon standing; mp 56-58°C; [ajo -34.6 (c = 1.0, MeOH).
1H NMR (CDCI3): b = 6.84 (d, J = 8.3 Hz, 1 H), 6.76 (dd, J = 8.3,
2.2 Hz, 1 H), 6.73 (d,J = 2.2 Hz, 1 H),4.77-4.71 (m, 1 H),4.14-4.10
(m, 1 H), 4.00-3.96 (m, 1 H), 3.85 (s, 3 H), 3.85-3.81 (m, 1 H),
3.32-3.26 (m, 1 H), 3.08 (dd, J = 17.8, 9.2 Hz, 1 H), 2.56 (dd,
J = 17.8,4.6 Hz, 1 H), 2.42 (t, J = 5.5 Hz, 1 H), 1.97-1.83 (m, 6 H),
1.64-1.60 (m, 2 H), 1.57 (s, 9 H).
13CNMR (CDCI3): b = 173.7, 150.8, 149.2, 148.1, 135.1, 118.6,
113.2,112.3,83.7,80.5,67.3,64.0,56.1,40.1,38.5,32.9, 28.0, 24.1.
IR (KBr): v = 3411, 1778, 1711, 1515, 1365, 1303, 1254, 1151 cm -l.
Anal. calcd for C22H3IN06: C, 65.15; H, 7.71; N, 3.46. Found: C,
64.95; H, 7.70; N, 3.28
(2S,3R)-I-tert-Butoxycarbonyl-3-(3-cyclopentyloxy-4-methoxy-
phenyl)-5-oxopyrrolidine-2-carboxylic Acid (7):
To a solution ofthe alcohol 6 (0.44 g, 1.09 mmol) in acetone (10 mL)
was added Jones reagentl5 (1.87 mL) at O°C. The mixture was
stirred for 90 min at O°C and for 90 min at r.t. before the addition
of propan-2-01 (1 mL). A satd aq solution of NaHC03 (10 mL) was
added and the mixture was extracted with EtOAc (3 x 10 mL). The
aqueous layer was acidified with 1N HCI and extracted with EtOAc
(3 x 10 mL). The combined organic layers were dried (MgS04) fil-
te red and concentrated in vacuo to give 7 (0.23 g; 50 %) as a white
solid; mp 63-65"C; [an° + 37.7 (c = 0.5, MeOH).
IH NMR (CDCl3): b = 6.81 (d, J = 8.5 Hz, 1 H), 6.74 (d,
J = 8.5 Hz, 1 H), 6.72 (s, 1 H), 4.75-4.72 (m, 1H), 4.56-4.52 (m,
1 H), 3.81 (s, 3 H), 3.50-3.45 (m, 1 H), 3.04 (dd, J = 17.5, 9.0 Hz,
1 H), 2.65 (dd, J = 17.5, 3.0 Hz, 1 H), 1.90-1.77 (m, 6 H), 1.60-1.56
(m, 2 H), 1.46 (s, 9 H).
13C NMR (CDCl3): b = 174.9, 172.8, 150.0, 149.2, 148.0, 133.4,
118.3,113.1,112.2,84.6,80.6,65.8,56.1,39.2,38.9, 32.7, 27.8, 24.0.
IR (KBr): v = 3436, 2965,1784,1747,1514,1306,1259,1152,910,
733cm-l.
Anal. calcd for C22H29N06: C, 62.98; H, 6.97; N, 3.34. Found: C,
62.65; H, 6.97; N, 3.19.
4-(3-Cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one (R)-( -)-
Rolipram (- )-1):
To a solution of acid 7 (60 mg, 0.143 mmol) in anhyd THF (1 mL)
under argon at -15°C was added N-methylmorpholine (0.016 mL,
0.143 mmol) and isobutyl chloroformate (0.018 mL, 0.143 mmol).
After stirring for 15 min at this temperature, a solution of N-hy-
droxy-2-thiopyridone (22 mg, 0.172 mmol) and Et3N (0.024 mL,
0.172 mmol) in anhyd THF (1 mL) was added. The mixture was
stirred at -15°C under argon, sheltered from light (aluminum foil),
for 1 h. The precipitate of N-methylmorpholine hydrochloride was
filtered and washed with more anhyd THF under protection from
light (aluminum foil). To the filtrate was added tert-butylthiol
(0.16 mL, 1.43 mmol) and the mixture was irradiated with two
100 watt tungsten lamps at r.t. under argon in a water bath for 1 h.
Et20 (5 mL) was added and the organic layer washed with 0.1 N
NaHC03 solution (2 x 5 mL), 0.5 N HCl (2 x 5 mL) and brine
(2 x 5 mL). The organic layer was dried (MgS04) and the solvent
evaporated. The remaining oil was purified by column chromatog-
raphy (hexane/EtOAc, 1: 1) to atrord 25 mg (64 %) of a white solid;
mp 130-132°C (Lit.1 mp 131-133°C; Lit.3 mp 126-128°C; Lit.6
mp 130-132°C); [ajo - 31.8 (c = 0.5, MeOH). (Lit1 [ajo - 31.0
(c = 0.5, MeOH); Lit3 [ajo -19.5 (c = 1.15, MeOH); Lit6 [ajo
- 30.2 (c = 0.1, MeOH)).
IHNMR (CDCl3): b = 6.80 (d, J = 7.8 Hz, 1 H), 6.75 (dd, J = 7.8,
2.0 Hz, 1 H), 6.74 (d, J = 2.0 Hz, 1H), 5.95 (br s, 1 H), 4.77-4.72
(m, 1 H), 3.81 (s, 3 H), 3.73 (app t, J = 8.5 Hz, 1 H), 3.61 (app p,
J = 8.5 Hz, 1 H), 3.35 (dd, J = 9.0, 7.5 Hz, 1 H), 2.69 (dd, J = 18.5,
8.5 Hz, 1 H), 2.45 (dd, J = 18.5, 9.0 Hz, 1 H), 1.90-1.79 (m, 6 H),
1.60-1.57 (m,2 H).
13CNMR (CDCI3): b = 177.5, 149.1, 147.9, 134.4, 118.7, 113.7,
112.1,80.5,56.1,49.7,40.0,38.0,32.8,24.0.




4-(3-Cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one [( ± )-Rolip-
ram, (±)-11:
The experimental procedure was identical to that described above
for 5. In this way the racemate (±)-1 (0.29 g, 81 %) was obtained
as a while solid; mp 130-131 °C (Lit.! mp 130°C).
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